ABVC Biopharma's auditor change confirmed via SEC consent letter dated July 1, 2026.
ABVC Biopharma addressed the SEC to validate the auditor change disclosed in its July 1, 2026 8-K. This documentation signifies compliance with procedural requirements for accounting firm transitions.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day